bariatric surgery and glp-1 Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide Semaglutide for the Treatment of Weight Regain After surgery: a Retrospective Observational Study Why Surgery Delivers Lasting Weight

Median time of exposure to treatment: 3.5 years

10.1016/s1388-2457(00)00253-4 94 LassmannH.van HorssenJ.MahadD

John Garrett is a Registered Nurse and biotech industry professional with a background spanning emergency medicine, intensive care, vascular access, cardiac cath lab medicine, and clinical biomarker science

Personalized Medical Oversight After approval, patients receive prescriptions for GLP-1 medications (such as semaglutide or tirzepatide), along with a customized dosing plan

Current evidence-based NHS treatment focuses on lifestyle modification including weight loss, dietary changes, and increased physical activity, which have the strongest evidence for improving liver health